CEFTRIAXONE TAMRISA 1 g, poudre pour solution injectable — 100 flacon(s) en verre

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400958218132
  • CIP7 5821813
  • CIS 64915021

What the source publishes

Holder
TAMRISA ACCESS (FRANCE)
Active ingredients
CEFTRIAXONE SODIQUE ANHYDRE, CEFTRIAXONE
Form
poudre pour solution injectable
Package
100 flacon(s) en verre
Routes
intramusculaire, intraveineuse
Administrative status
authorised
Supply regime
liste I
Marketing status
Déclaration d'arrêt de commercialisation
Authorised on
2012-03-05
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400958218132
{
  "cis": "64915021",
  "cip7": "5821813",
  "form": "poudre pour solution injectable",
  "name": "CEFTRIAXONE TAMRISA 1 g, poudre pour solution injectable — 100 flacon(s) en verre",
  "cip13": "3400958218132",
  "holder": "TAMRISA ACCESS (FRANCE)",
  "routes": [
    "intramusculaire",
    "intraveineuse"
  ],
  "holders": [
    "TAMRISA ACCESS (FRANCE)"
  ],
  "currency": "EUR",
  "marketed": false,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": null,
  "authorisedOn": "2012-03-05",
  "compositions": [
    {
      "name": "CEFTRIAXONE SODIQUE ANHYDRE",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "19091",
      "dosageReference": null,
      "pharmaceuticalElement": "poudre"
    },
    {
      "name": "CEFTRIAXONE",
      "nature": "FT",
      "strength": "1 g",
      "linkageNumber": "1",
      "substanceCode": "35232",
      "dosageReference": "un flacon de poudre pour solution injectable",
      "pharmaceuticalElement": "poudre"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": null,
  "medicinePrice": null,
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "CEFTRIAXONE TAMRISA 1 g, poudre pour solution injectable",
  "marketingStatus": "Déclaration d'arrêt de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "100 flacon(s) en verre",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [],
  "marketingDeclaredOn": "2025-09-01",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "CEFTRIAXONE SODIQUE ANHYDRE",
    "CEFTRIAXONE"
  ],
  "authorisationProcedure": "Procédure nationale",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400958218132"